Chandra Vargeese - Jan 23, 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Technology Officer, Head of Platform Discovery Sciences
Signature
/s/ Chandra Vargeese
Stock symbol
WVE
Transactions as of
Jan 23, 2025
Transactions value $
$114,080
Form type
4
Date filed
1/24/2025, 05:30 PM
Previous filing
Jul 24, 2024
Next filing
Feb 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Options Exercise $114K +46K +24.48% $2.48 234K Jan 23, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Options Exercise $0 -46K -73.69% $0.00 16.4K Jan 23, 2025 Ordinary Shares 46K $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,872 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.
F2 The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Remarks:

Chief Technology Officer, Head of Platform Discovery Sciences